SVB Financial Group
- SEC CIK
- 0000719739
- Latest filing
- Nov 10, 2025
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 21
- −3 vs. Q2 2023
- Portfolio value
- $53.2M
- +$251.3K (+0.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| COINCoinbase Global, Inc. | COM CL A | 406,973 | $30.6M | 57.5% | 00.0% | Unchanged | History |
| ROOTRoot, Inc. | CL A NEW | 783,012 | $7.45M | 14.0% | 00.0% | Unchanged | History |
| OKTAOkta, Inc. | CL A | 79,152 | $6.45M | 12.1% | −20,720−20.7% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 33,849 | $2.37M | 4.5% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 35,353 | $1.78M | 3.4% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 127,068 | $1.11M | 2.1% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 16,173 | $921.9K | 1.7% | 00.0% | Unchanged | History |
| ROVRRover Group, Inc. | COMMON STOCK | 105,534 | $660.6K | 1.2% | 00.0% | Unchanged | History |
| CMAXCareMax, Inc. | COM CL A | 300,000 | $636.0K | 1.2% | 00.0% | Unchanged | History |
| PLPlanet Labs PBC | COM CL A | 172,097 | $447.5K | 0.8% | 00.0% | Unchanged | History |
| GLBEGlobal-E Online Ltd. | SHS | 5,114 | $203.2K | 0.4% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 13,516 | $122.3K | 0.2% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 20,714 | $99.0K | 0.2% | 00.0% | Unchanged | History |
| GBIOGeneration Bio Co. | COM | 25,034 | $94.9K | 0.2% | −2,848−10.2% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 10,249 | $85.6K | 0.2% | 00.0% | Unchanged | History |
| FIRYFiry Inc. | COM | 13,950 | $71.1K | 0.1% | +254+1.9% | Added | History |
| KLRSKalaris Therapeutics, Inc. | COM | 17,207 | $37.0K | 0.1% | −8,604−33.3% | Reduced | History |
| MVLAMovella Holdings Inc. | COM | 55,528 | $29.8K | 0.1% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 10,667 | $20.9K | <0.1% | 00.0% | Unchanged | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 13,472 | $18.5K | <0.1% | −4,553−25.3% | Reduced | History |
| MKULMolekule Group, Inc. | COM | 21,247 | $3.08K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2023 (3)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 21,799 | $1.01M | 1.9% | History |
| PRDSPardes Biosciences, Inc. | COM | 35,923 | $65.0K | 0.1% | History |
| GRNAGreenLight Biosciences Holdings, PBC | COMMON STOCK | 16,950 | $5.08K | <0.1% | History |